Loading...
XCNQ
IME
Market cap114kUSD
Feb 02, Last price  
0.02CAD
Name

Imagin Medical Inc

Chart & Performance

D1W1MN
XCNQ:IME chart
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
0k
1,883646000000000000000000
Net income
-2m
L-78.28%
-521,059-134,233-1,356,000-1,348,996-2,157,548-8,052,000-5,614,000-64,292-1,739,000-1,893,000-493,373-2,014,000-402,757-2,259,571-1,542,102-7,958,000-4,464,541-4,376,849-11,473,000-2,492,000
CFO
-3m
L-35.83%
-80,877-199,279-299,291-778,811-1,323,383-174,012-507,236-472,891-525,086-364,381-403,860-456,384-256,423-1,404,217-664,319-4,629,592-4,037,376-4,111,989-4,094,026-2,627,210

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Imagin Medical Inc., a urologic oncology company, focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. It has a license agreement with Lawrence Livermore National Security, LLC to develop, manufacture, and sell a medical imaging device. The company is headquartered in Vancouver, Canada.
URL
https://imaginmedical.com/
IPO date
Apr 30, 1987
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2022‑092021‑092020‑092019‑092018‑092017‑092016‑09
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT